India Today on MSN2h
Why India has a vital role in Parkinson’s Disease researchParkinson’s Disease has no cure. However, various treatment options can manage the symptoms and improve the quality of life ...
Manufactured by AbbVie, Produodopa is a subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe ...
Levodopa-induced dyskinesia (LID) is a common complication after dopamine-replacement therapy in Parkinson's disease. The neural mechanisms underlying LID are far from clear, although significant ...
US Neurologists express enthusiasm for new ways to administer current treatments and future disease modifying therapies, according to .Exton, Pennsylvania, May 09, 2024 (GLOBE NEWSWIRE) -- Even as the ...
At 28 years old, Dr. Soania Mathur was building her medical practice and expecting her first child. Then she was diagnosed ...
Deep brain stimulation is a game-changer for patients like Peters amid the ongoing fight for medical breakthroughs for ...
Leerink Partners analyst Thomas Smith has reiterated their bullish stance on TRVI stock, giving a Buy rating yesterday. Thomas Smith has given ...
El País in English on MSN12d
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson’sA clinical trial shows the neuroprotective effect of lixisenatide, a GLP-1 receptor agonist. Its use during a year prevented ...
Despite the short half-life of levodopa, in early PD, the symptomatic benefit of levodopa/DDCI appears to last from dose to dose when administered on a three- or four-times daily schedule.
Global Parkinson’s Disease Industry likely to raise at a CAGR of 5.1% and may surpass US$ 3.7 billion during forecast period ...
In this article, we will address the diagnosis of INPH, discuss features that might differentiate PD from INPH, and review the use of the levodopa challenge test, which can be a useful diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback